Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame
批准号:
10202626
负责人:
Mayland F Chang
金额:
$28.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2022-06-30
中文摘要
摘要
圣母大学的化学-生物化学-生物学接口(CBBI)课程是一个
建立了由NIH资助的项目,该项目在多学科环境中培训研究生,提供
他们在化学和生物相关学科的界面上接受了大量的培训。CBBI的目标是
培养的是博士生,他们在学生的核心学科、交叉学科方面都有深入的训练
培训以有效地在界面上工作,并增强跨学科的沟通技能。CBBI
该项目非常成功,为我们的博士前培养创造了良好的环境
实习生。自2007年以来,我们培养了55名学生,其中33人平均获得博士学位
5.19岁,包括8名任职人数不足的少数民族,其中6人已获得博士学位。
我们的55名学员有207种出版物,其中94种是第一作者出版物。这代表了3.76种出版物
每名学员出版1.71本第一作者出版物。8个市建局共出版了37份刊物,其中
17篇是第一作者出版物;这相当于每个URM有4.63篇出版物,每个URM有2.13篇第一作者出版物
嗯。在过去的9年里,我们的流失率非常低,55名受训人员中只有3人(5.5%)
没有完成博士学位。在过去的5年里,没有一个学员离开该项目时没有获得博士学位。
年,当前周期的培训方案。CBBI计划的特点包括:大型
申请者人才库高素质的候选人,良好的合作和多学科研究记录,
由经验丰富、富有成效且由联邦政府资助的调查人员组成的多样而强大的团队可担任
研究导师,在导师的实验室外延长的跨学科研究实习,培训
补充多学科研讨会、实习生会议、年度研讨会、经验丰富的
有效的计划管理、持续评估和改进培训的机制
项目,专业发展和职业安置,一流的研究设施和强大的机构
承诺。我们建议继续培训具有解决挑战的技能和专业知识的博士科学家
生物医学问题,与学科无关。圣母大学对此表示热烈支持
培训计划,并将继续为CBBI计划提供慷慨的奖学金匹配和其他
资源,包括所有受训人员的研究实习费用,在国家卫生研究院续签资金后。
英文摘要
Abstract
The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame is an
established NIH-funded program, which trains graduate students in a multidisciplinary environment that provides
them with significant training at the interface of chemistry and biology-related disciplines. The goal of the CBBI
Program is to produce PhD scientists who have in-depth training in the student's core discipline, cross-discipline
training to work effectively at the interface, and enhanced interdisciplinary communication skills. The CBBI
Program has been very successful and has established an outstanding training environment for our predoctoral
trainees. Since 2007 we have trained 55 students, 33 of whom have completed PhD degrees in an average of
5.19 years, including 8 underrepresented minorities (URMs), 6 of whom have already received PhD degrees.
Our 55 trainees have 207 publications, of which 94 are first-author publications. This represents 3.76 publications
per trainee and 1.71 first-author publications per trainee. The 8 URMs have produced 37 publications, of which
17 are first-author publications; this represents 4.63 publications per URM and 2.13 first-author publications per
URM. During the past 9 years, our attrition rate has been extremely low, with only 3 of 55 trainees (5.5%) who
did not complete a PhD degree. Not a single trainee has left the program without a PhD degree in the past 5
years, the current cycle of the training program. The characteristics of the CBBI Program include: a large
applicant pool of highly qualified candidates, a strong record of collaborative and multidisciplinary research, a
diverse and strong group of experienced, productive, and federally-funded investigators available to serve as
research mentors, an extended cross-disciplinary research internship outside the mentor's laboratory, training
supplementation with multidisciplinary seminars, trainee meetings, an annual symposium, experienced and
effective program administration, mechanisms for continuous evaluation and improvement of the training
program, professional development and career placement, excellent research facilities, and strong institutional
commitment. We propose to continue to train PhD scientists with the skills and expertise to solve challenging
biomedical problems, regardless of discipline. The University of Notre Dame enthusiastically supports this
training program, and will continue to provide a generous fellowship match to the CBBI Program and additional
resources, including the cost of the research internship for all trainees, upon renewal of funding by the NIH.
期刊论文(235)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.
锌(II)-二吡啶胺配位络合物作为重大利什曼原虫的靶向剂和化疗剂。
DOI:
10.1128/aac.00410-16
发表时间:
2016
期刊:
Antimicrobial agents and chemotherapy
影响因子:
4.9
作者:
[Rice,DouglasR, Vacchina,Paola, Norris-Mullins,Brianna, Morales,MiguelA, Smith,BradleyD]
通讯作者:
Smith,BradleyD
Iron(III)-templated macrolactonization of trihydroxamate siderophores.
三异羟肟酸铁载体的铁(III)模板化大内酯化。
DOI:
10.1021/ol301869x
发表时间:
2012
期刊:
Organic letters
影响因子:
5.2
作者:
[Wencewicz,TimothyA, Oliver,AllenG, Miller,MarvinJ]
通讯作者:
Miller,MarvinJ
Using MTBindingSim as a tool for experimental planning and interpretation.
使用 MTBindingSim 作为实验规划和解释的工具。
DOI:
10.1016/b978-0-12-407757-7.00023-2
发表时间:
2013
期刊:
Methods in cell biology
影响因子:
--
作者:
[Philip,JuliaT, Duan,ArandaR, Alberico,EmilyO, Goodson,HollyV]
通讯作者:
Goodson,HollyV
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
DOI:
10.1158/2767-9764.crc-23-0327
发表时间:
2024-01-31
期刊:
Cancer research communications
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/jmr.896
发表时间:
2008-07
期刊:
JOURNAL OF MOLECULAR RECOGNITION
影响因子:
2.7
作者:
[Armstrong, Kathryn M., Insaidoo, Francis K., Baker, Brian M.]
通讯作者:
Baker, Brian M.
共 167 条
The quinazolinone class of antibacterial agents
-
批准号:9222697
-
项目类别:
-
资助金额:$60.2万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
The quinazolinone class of antibacterial agents
-
批准号:8856982
-
项目类别:
-
资助金额:$63.39万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
The quinazolinone class of antibacterial agents
-
批准号:9037579
-
项目类别:
-
资助金额:$60.2万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8692635
-
项目类别:
-
资助金额:$99.05万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8485537
-
项目类别:
-
资助金额:$94.4万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8288684
-
项目类别:
-
资助金额:$101.68万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8105043
-
项目类别:
-
资助金额:$101.91万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:7988818
-
项目类别:
-
资助金额:$106.96万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8689089
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7900621
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7665470
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:9101816
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7370934
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:8119558
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8268162
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8501527
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7494485
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
STRUCTURE ELUCIDATION OF OLIGOSACHARIDES BY FAB-MS
-
批准号:3042854
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1988
-
负责人:Mayland F Chang
-
依托单位:
STRUCTURE ELUCIDATION OF OLIGOSACHARIDES BY FAB-MS
-
批准号:3042855
-
项目类别:
-
资助金额:$0.83万
-
财政年份:1988
-
负责人:Mayland F Chang
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: